Skip to content
1887

Abstract

Human immunodeficiency virus type 1 (HIV-1) causes a major burden on global health, and eradication of latent virus infection is one of the biggest challenges in the field. The circadian clock is an endogenous timing system that oscillates with a ~24 h period regulating multiple physiological processes and cellular functions, and we recently reported that the cell intrinsic clock regulates rhythmic HIV-1 replication. Salt inducible kinases (SIK) contribute to circadian regulatory networks, however, there is limited evidence for SIKs regulating HIV-1 infection. Here, we show that pharmacological inhibition of SIKs perturbed the cellular clock and reduced rhythmic HIV-1 replication in circadian synchronised cells. Further, SIK inhibitors or genetic silencing of expression inhibited viral replication in primary cells and in a latency model, respectively. Overall, this study demonstrates a role for salt inducible kinases in regulating HIV-1 replication and latency reactivation, which can provide innovative routes to better understand and target latent HIV-1 infection.

Funding
This study was supported by the:
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (Award UM1-AI-164567)
    • Principle Award Recipient: PersephoneBorrow
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine (Award 2018-I2M-2-002)
    • Principle Award Recipient: JaneA McKeating
  • Medical Research Foundation (Award MR/R022011/1)
    • Principle Award Recipient: JaneA McKeating
  • Wellcome Trust (Award 200838/Z/16/Z)
    • Principle Award Recipient: JaneA McKeating
  • Indonesia Endowment Fund for Education
    • Principle Award Recipient: DiniIsmed
  • Wellcome Trust (Award 108869/Z/15/Z)
    • Principle Award Recipient: BorrmannHelene
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001877
2023-08-02
2025-01-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/104/8/jgv001877.html?itemId=/content/journal/jgv/10.1099/jgv.0.001877&mimeType=html&fmt=ahah

References

  1. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 2014; 384:258–271 [View Article] [PubMed]
    [Google Scholar]
  2. Dahabieh MS, Battivelli E, Verdin E. Understanding HIV latency: the road to an HIV cure. Annu Rev Med 2015; 66:407–421 [View Article] [PubMed]
    [Google Scholar]
  3. Thorlund K, Horwitz MS, Fife BT, Lester R, Cameron DW. Landscape review of current HIV “kick and kill” cure research - some kicking, not enough killing. BMC Infect Dis 2017; 17:595 [View Article] [PubMed]
    [Google Scholar]
  4. Ait-Ammar A, Kula A, Darcis G, Verdikt R, De Wit S et al. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front Microbiol 2019; 10:3060 [View Article] [PubMed]
    [Google Scholar]
  5. Ahlenstiel CL, Symonds G, Kent SJ, Kelleher ADB, Lock HIV. Block and lock HIV cure strategies to control the latent reservoir. Front Cell Infect Microbiol 2020; 10:424 [View Article] [PubMed]
    [Google Scholar]
  6. Borrmann H, McKeating JA, Zhuang X. The circadian clock and viral infections. J Biol Rhythms 2021; 36:9–22 [View Article] [PubMed]
    [Google Scholar]
  7. Zhuang X, Forde D, Tsukuda S, D’Arienzo V, Mailly L et al. Circadian control of hepatitis B virus replication. Nat Commun 2021; 12:1658 [View Article] [PubMed]
    [Google Scholar]
  8. Edgar RS, Stangherlin A, Nagy AD, Nicoll MP, Efstathiou S et al. Cell autonomous regulation of herpes and influenza virus infection by the circadian clock. Proc Natl Acad Sci U S A 2016; 113:10085–10090 [View Article] [PubMed]
    [Google Scholar]
  9. Wang C, Lutes LK, Barnoud C, Scheiermann C. The circadian immune system. Sci Immunol 2022; 7:eabm2465 [View Article] [PubMed]
    [Google Scholar]
  10. Rijo-Ferreira F, Takahashi JS. Genomics of circadian rhythms in health and disease. Genome Med 2019; 11:82 [View Article] [PubMed]
    [Google Scholar]
  11. Stern J, Solomon A, Dantanarayana A, Pascoe R, Reynaldi A et al. Cell-associated human immunodeficiency virus (HIV) ribonucleic acid has a circadian cycle in males with HIV on antiretroviral therapy. J Infect Dis 2022; 225:1721–1730 [View Article] [PubMed]
    [Google Scholar]
  12. Chang CC, Naranbhai V, Stern J, Roche M, Dantanarayana A et al. Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1. AIDS 2018; 32:2119–2128 [View Article] [PubMed]
    [Google Scholar]
  13. Borrmann H, Davies R, Dickinson M, Pedroza-Pacheco I, Schilling M et al. Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication. Sci Rep 2020; 10:13271 [View Article] [PubMed]
    [Google Scholar]
  14. Borrmann H, Ulkar G, Kliszczak AE, Ismed D, Schilling M et al. Circadian regulation of human immunodeficiency virus type 1 replication. bioRxiv 2022 [View Article]
    [Google Scholar]
  15. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol 2014; 24:90–99 [View Article] [PubMed]
    [Google Scholar]
  16. Jagannath A, Taylor L, Ru Y, Wakaf Z, Akpobaro K et al. The multiple roles of salt-inducible kinases in regulating physiology. Physiol Rev 2023; 103:2231–2269 [View Article] [PubMed]
    [Google Scholar]
  17. Darling NJ, Cohen P. Nuts and bolts of the salt-inducible kinases (SIKs). Biochem J 2021; 478:1377–1397 [View Article] [PubMed]
    [Google Scholar]
  18. Wein MN, Foretz M, Fisher DE, Xavier RJ, Kronenberg HM. Salt-Inducible kinases: physiology, regulation by cAMP, and therapeutic potential. Trends Endocrinol Metab 2018; 29:723–735 [View Article] [PubMed]
    [Google Scholar]
  19. Jagannath A, Butler R, Godinho SIH, Couch Y, Brown LA et al. The CRTC1-SIK1 pathway regulates entrainment of the circadian clock. Cell 2013; 154:1100–1111 [View Article]
    [Google Scholar]
  20. Hayasaka N, Hirano A, Miyoshi Y, Tokuda IT, Yoshitane H et al. Salt-inducible kinase 3 regulates the mammalian circadian clock by destabilizing PER2 protein. eLife 2017; 6: [View Article]
    [Google Scholar]
  21. De Martini W, Rahman R, Ojegba E, Jungwirth E, Macias J et al. Kinases: understanding their role in HIV infection. World J AIDS 2019; 9:142–160 [View Article] [PubMed]
    [Google Scholar]
  22. Duverger A, Wolschendorf F, Anderson JC, Wagner F, Bosque A et al. Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation. J Virol 2014; 88:364–376 [View Article] [PubMed]
    [Google Scholar]
  23. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 2003; 100:7271–7276 [View Article] [PubMed]
    [Google Scholar]
  24. Vermeire J, Naessens E, Vanderstraeten H, Landi A, Iannucci V et al. Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. PLoS One 2012; 7:e50859 [View Article] [PubMed]
    [Google Scholar]
  25. Zielinski T, Moore AM, Troup E, Halliday KJ, Millar AJ. Strengths and limitations of period estimation methods for circadian data. PLoS One 2014; 9:e96462 [View Article] [PubMed]
    [Google Scholar]
  26. Wang Z, Ma J, Miyoshi C, Li Y, Sato M et al. Quantitative phosphoproteomic analysis of the molecular substrates of sleep need. Nature 2018; 558:435–439 [View Article] [PubMed]
    [Google Scholar]
  27. Tesch R, Rak M, Raab M, Berger LM, Kronenberger T et al. Structure-based design of selective salt-inducible kinase inhibitors. J Med Chem 2021; 64:8142–8160 [View Article] [PubMed]
    [Google Scholar]
  28. Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 2009; 139:199–210 [View Article] [PubMed]
    [Google Scholar]
  29. Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998; 93:929–937 [View Article] [PubMed]
    [Google Scholar]
  30. Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 2003; 22:1868–1877 [View Article] [PubMed]
    [Google Scholar]
  31. Lu Y, Bohn-Wippert K, Pazerunas PJ, Moy JM, Singh H et al. Screening for gene expression fluctuations reveals latency-promoting agents of HIV. Proc Natl Acad Sci U S A 2021; 118:e2012191118 [View Article] [PubMed]
    [Google Scholar]
  32. Zhuang X, Pedroza-Pacheco I, Nawroth I, Kliszczak AE, Magri A et al. Hypoxic microenvironment shapes HIV-1 replication and latency. Commun Biol 2020; 3:376 [View Article] [PubMed]
    [Google Scholar]
  33. Yukl SA, Kaiser P, Kim P, Telwatte S, Joshi SK et al. HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Sci Transl Med 2018; 10:eaap9927 [View Article] [PubMed]
    [Google Scholar]
  34. Telwatte S, Morón-López S, Aran D, Kim P, Hsieh C et al. Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency. Retrovirology 2019; 16: [View Article]
    [Google Scholar]
  35. Ma L, Chen S, Wang Z, Guo S, Zhao J et al. The CREB regulated transcription coactivator 2 suppresses HIV-1 transcription by preventing RNA Pol II from binding to HIV-1 LTR. Virol Sin 2021; 36:796–809 [View Article]
    [Google Scholar]
  36. Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E. Reactivation of latent HIV by histone deacetylase inhibitors. Trend Microbiol 2013; 21:277–285 [View Article]
    [Google Scholar]
  37. Archin NM, Keedy KS, Espeseth A, Dang H, Hazuda DJ et al. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS 2009; 23:1799–1806 [View Article] [PubMed]
    [Google Scholar]
  38. Parra M. Class IIa HDACs - new insights into their functions in physiology and pathology. FEBS J 2015; 282:1736–1744 [View Article]
    [Google Scholar]
  39. Zaikos TD, Painter MM, Sebastian Kettinger NT, Terry VH, Collins KL. Class 1-selective histone deacetylase (HDAC) inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression. J Virol 2018; 92:e02110–02117 [View Article] [PubMed]
    [Google Scholar]
  40. Sun Z, Jiang Q, Li J, Guo J. The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis. Signal Transduct Target Ther 2020; 5:150 [View Article] [PubMed]
    [Google Scholar]
  41. Sundberg TB, Choi HG, Song J-H, Russell CN, Hussain MM et al. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells. Proc Natl Acad Sci U S A 2014; 111:12468–12473 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.001877
Loading
/content/journal/jgv/10.1099/jgv.0.001877
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error